Long-term effects of complex decongestive therapy in breast cancer patients with arm lymphedema after axillary dissection

Annals of Rehabilitation Medicine

Volumn 37, Issue 5, 2013, Pages 690-697

  Hwang, Jung Min ^a   Hwang, Ji Hye ^a   Kim, Tae Won ^a   Lee, Seung Yeol ^a   Chang, Hyun Ju ^a   Chu, In Ho ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Breast neoplasms; Lymphedema; Physical therapy modalities

Indexed keywords

EID: 84887125758     PISSN: 22340645     EISSN: 22340653     Source Type: Journal    
DOI: 10.5535/arm.2013.37.5.690     Document Type: Article

References (38)

1. Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. J Clin Oncol 2008;26:5689-96.
2. Pusic AL, Cemal Y, Albornoz C, Klassen A, Cano S, Sulimanoff I, et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv 2013;7:83-92.
3. Shah C, Vicini FA. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. Int J Radiat Oncol Biol Phys 2011;81:907-14.
4. Gartner R, Jensen MB, Kronborg L, Ewertz M, Kehlet H, Kroman N. Self-reported arm-lymphedema and functional impairment after breast cancer treatment: a nationwide study of prevalence and associated factors. Breast 2010;19:506-15.
5. Ashikaga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010;102:111-8.
6. Mouridsen HT, Bjerre KD, Christiansen P, Jensen MB, Moller S. Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG Registry. Acta Oncol 2008;47:525-36.
7. Miller CL, Specht MC, Skolny MN, Jammallo LS, Horick N, O'Toole J, et al. Sentinel lymph node biopsy at the time of mastectomy does not increase the risk of lymphedema: implications for prophylactic surgery. Breast Cancer Res Treat 2012;135:781-9.
8. Foldi E, Foldi M, Clodius L. The lymphedema chaos: a lancet. Ann Plast Surg 1989;22:505-15.
9. Vignes S, Porcher R, Arrault M, Dupuy A. Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy. Breast Cancer Res Treat 2007;101:285-90.
10. Ko DS, Lerner R, Klose G, Cosimi AB. Effective treatment of lymphedema of the extremities. Arch Surg 1998;133:452-8
11. Vignes S, Porcher R, Arrault M, Dupuy A. Factors influencing breast cancer-related lymphedema volume after intensive decongestive physiotherapy. Support Care Cancer 2011;19:935-40.
12. Vignes S, Porcher R, Champagne A, Dupuy A. Predictive factors of response to intensive decongestive physiotherapy in upper limb lymphedema after breast cancer treatment: a cohort study. Breast Cancer Res Treat 2006;98:1-6.
13. Kim YB, Hwang JH, Kim TW, Chang HJ, Lee SG. Would complex decongestive therapy reveal long term effect and lymphoscintigraphy predict the outcome of lower-limb lymphedema related to gynecologic cancer treatment? Gynecol Oncol 2012;127:638-42.
14. Ramos SM, O'Donnell LS, Knight G. Edema volume, not timing, is the key to success in lymphedema treatment. Am J Surg 1999;178:311-5.
15. Forner-Cordero I, Munoz-Langa J, Forner-Cordero A, De Miguel-Jimeno JM. Predictive factors of response to decongestive therapy in patients with breast-cancer-related lymphedema. Ann Surg Oncol 2010;17:744-51.
16. Bernas MJ, Witte CL, Witte MH; International Society of Lymphology Executive Committee. The diagnosis and treatment of peripheral lymphedema: draft revision of the 1995 Consensus Document of the International Society of Lymphology Executive Committee for discussion at the September 3-7, 2001, XVIII International Congress of Lymphology in Genoa, Italy. Lymphology 2001;34:84-91.
17. Szuba A, Cooke JP, Yousuf S, Rockson SG. Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema. Am J Med 2000;109:296-300.
18. Piller N, Carati C. The diagnosis and treatment of peripheral lymphedema. Lymphology 2009;42:146-7.
19. Stillwell GK. Treatment of postmastectomy lymphedema. Mod Treat 1969;6:396-412.
20. Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, Wanchai A, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R 2012;4:580-601.
21. Stanton AW, Northfield JW, Holroyd B, Mortimer PS, Levick JR. Validation of an optoelectronic limb volumeter (Perometer). Lymphology 1997;30:77-97.
22. Tierney S, Aslam M, Rennie K, Grace P. Infrared optoelectronic volumetry, the ideal way to measure limb volume. Eur J Vasc Endovasc Surg 1996;12:412-7.
23. Ancukiewicz M, Miller CL, Skolny MN, O'Toole J, Warren LE, Jammallo LS, et al. Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology. Breast Cancer Res Treat 2012;135:145-52.
24. Johansson K, Branje E. Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis. Acta Oncol 2010;49:166-73.
25. O'Toole J, Jammallo LS, Skolny MN, Miller CL, Elliott K, Specht MC, et al. Lymphedema following treatment for breast cancer: a new approach to an old problem. Crit Rev Oncol Hematol 2013 Jun 15 [E-pub]. http://dx.doi.org/10.1016/j.critrevonc.2013.05.001.
26. Helyer LK, Varnic M, Le LW, Leong W, McCready D. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J 2010;16:48-54.
27. Sitzia J, Stanton AW, Badger C. A review of outcome indicators in the treatment of chronic limb oedema. Clin Rehabil 1997;11:181-91.
28. Gebruers N, Truijen S, Engelborghs S, De Deyn PP. Volumetric evaluation of upper extremities in 250 healthy persons. Clin Physiol Funct Imaging 2007;27:17-22.
29. Liao SF, Huang MS, Li SH, Chen IR, Wei TS, Kuo SJ, et al. Complex decongestive physiotherapy for patients with chronic cancer-associated lymphedema. J Formos Med Assoc 2004;103:344-8.
30. Yamamoto R, Yamamoto T. Effectiveness of the treatment-phase of two-phase complex decongestive physiotherapy for the treatment of extremity lymphedema. Int J Clin Oncol 2007;12:463-8.
31. Casley-Smith JR. Alterations of untreated lymphedema and it's grades over time. Lymphology 1995; 28:174-85.
32. Bar Ad V, Dutta PR, Solin LJ, Hwang WT, Tan KS, Both S, et al. Time-course of arm lymphedema and potential risk factors for progression of lymphedema after breast conservation treatment for early stage breast cancer. Breast J 2012;18:219-25.
33. Liao SF, Li SH, Huang HY, Chen ST, Kuo SJ, Chen DR, et al. The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of lymphedema severity and response to CDP in breast cancer-related lymphedema (BCRL). Breast 2013;22:703-6.
34. Cheifetz O, Haley L; Breast Cancer Action. Management of secondary lymphedema related to breast cancer. Can Fam Physician 2010;56:1277-84.
35. Hamner JB, Fleming MD. Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer. Ann Surg Oncol 2007;14:1904-8.
36. Korpan MI, Crevenna R, Fialka-Moser V. Lymphedema: a therapeutic approach in the treatment and rehabilitation of cancer patients. Am J Phys Med Rehabil 2011;90:S69-75.
37. Jeffs E. Treating breast cancer-related lymphoedema at the London Haven: clinical audit results. Eur J Oncol Nurs 2006;10:71-9.
38. Williams AF, Vadgama A, Franks PJ, Mortimer PS. A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. Eur J Cancer Care (Engl) 2002;11:254-61.